The NO-cGMP pathway has been implicated in clitoral and vaginal smooth muscle relaxation based on previous immunochemical, biochemical and physiologic studies. There are limited data from in vivo studies demonstrating enhancement of the genital sexual arousal response by pharmacologic agents in¯uencing the NO-cGMP pathway. The goal of this study was to investigate if sildena®l, a phosphodiesterase type-5 inhibitor, facilitated female genital sexual arousal in an animal model in response to pelvic nerve stimulation (PNS).
Introduction
Female genital sexual arousal is a neurovascular process involving smooth muscle relaxation of the arteries, clitoral and labial erectile tissue and vaginal muscularis, resulting in increased genital blood¯ow and genital engorgement. The female genital sexual arousal response is characterized by physiologic changes including increased volume of the vaginal canal, clitoris and labia, increased vaginal pH, increased production of vaginal¯uid transudate, decreased vaginal luminal pressure, increased vaginal compliance, and increased vaginal wall pressure. 1 ± 5 The physiologic and biochemical mechanisms of arousal regulating genital smooth muscle relaxation involve multiple signaling pathways. 6 ± 10 Studies from several laboratories have suggested that the NO-cGMP pathway may play a role among other pathways in clitoral and vaginal smooth muscle relaxation. 9 ± 10 We have shown that smooth muscle cells cultured from human and rabbit clitoral and vaginal tissue express phosphodiesterase (PDE) type 5 activity. 11 ± 12 Sildena®l relaxes vaginal and clitoral tissue strips in organ baths and increases cGMP accumulation in smooth muscle cells cultured from vaginal and clitoral tissue. 11 ± 12 One of the limitations of physiologic investigation of female genital sexual arousal is quantitative assessment of the arousal response. Recent advances in the measurement of hemoglobin by laser oximetry 13 have facilitated quantitation of changes in blood¯ow in female genital (vaginal, labial, clitoral) tissues. We have employed this technology, along with laser Doppler¯owmetry, to assess the effect of pelvic nerve stimulation on genital tissue engorgement. We also assessed changes in vaginal luminal pressure and vaginal lubrication during pelvic nerve stimulation. The goal of this study was to investigate if sildena®l facilitates nerve-mediated genital sexual arousal utilizing this new methodology of quantifying female genital arousal responses in an animal model.
Materials and methods

Animals
Female New Zealand White rabbits (3.5 ± 4.0 kg) were sedated with subcutaneous ketamine (35 mgakg) and xylazine (5 mgakg) and secured in the supine position. Anesthesia was maintained as needed with intravenous sodium pentobarbital (50 mgaml). Following anesthesia, a 3 cm midline neck incision was fashioned to access the carotid artery. A 20-gauge angiocatheter was inserted into the carotid artery and connected to a PT300 pressure transducer (Grass InstrumentsaAstro-Med, Inc., Warwick, RI) to continuously monitor systemic blood pressure. Body temperature was maintained using an electric heat pad.
Pelvic nerve stimulation (PNS)
A 4 cm lower mid-line abdominal incision was fashioned to expose the pelvic nerve bearing relation to the postero-lateral aspect of rectum and vaginal wall. Bladder contents were aspirated through the bladder wall with an 18 gauge needle and 50 ml syringe. Under direct vision, a bipolar platinum wire electrode was hooked onto the pelvic nerve without cutting the nerve. Unilateral PNS was accomplished with a Grass S9 stimulator set at normal polarity and repeat mode to generate a 30 second train of square waves with 10 V pulse amplitude, 0.8 msec pulse duration and varying frequencies (4 ± 32 Hz). The interval between stimulations was 10 ± 15 min to prevent nerve exhaustion. Physiological parameters were measured at baseline, and then during and after PNS with and without sildena®l. Sildena®l (0.21 mgakg, 0.42 mgakg, 2.1 mgakg) was administered intravenously through an ear vein to achieve estimated systemic total (bound and free) plasma concentrations of 5, 10 and 50 nM, respectively. Twenty minutes after sildena®l administration, PNS was initiated. All pressure and blood¯ow measurements were recorded by means of PI-1-ACDC signal conditioner modules connected to a Grass 7400 physiological recorder (Astro-Med Inc. Warwick, RI).
Administration of sildena®l
Sildena®l solution was made in sterile physiological saline. We estimated the total blood volume in a 4 kg rabbit to be approximately 250 ml. The doses of sildena®l administered in this study were 0.21, 0.42 and 2.1 mgakg, respectively. Based on the estimated total blood volume, the total concentration (bound and free) of sildena®l in the plasma is expected to be, 5, 10 and 50 nM, respectively. For this reason, the data in the ®gures and the tables in this article are noted in nM of total sildena®l in the plasma. This does not take into account the metabolism or the partitioning of sildena®l by plasma proteins.
Physiologic outcome variables
We used four physiologic outcome variables to quantify the genital arousal response to PNS with and without sildena®l in anesthetized female rabbits.
(1) Laser Oximetry ± measurements of hemoglobin and oxygen saturation in genital (vaginal, labial and clitoral) tissues. Laser oximetry utilizes a continuous wave optical spectrometer with a ®ber optic array probe consisting of one detector and 8 light sources. The sources emit light in the near infrared spectrum (700 ± 900 nm) which can penetrate a targeted volume of tissue (530 mm 3 ) to an average depth of 7.2 mm beneath the optical ®bers. Taking into account the light scattering properties of the tissue, absorption by oxyhemoglobin and deoxyhemoglobin can be quanti®ed and tissue oxygen saturation levels and concentrations of oxyhemoglobin, deoxyhemoglobin and total hemoglobin can be calculated. Laser oximetry can thus be utilized to assess local tissue hemodynamics and oxygenation in a non-invasive and continuous fashion.
A dual channel oximeter (model 96208; ISS, Inc., Champaign, IL) was utilized. The skin around the labia was carefully shaved to ensure good contact with the optical ®bers. The probe (2 cm in length) was positioned longitudinally, externally over the clitoris, labia and lower vagina such that the detector ®ber was positioned just below the pubic arch. The probe assembly was secured in place by a metal stand. The area over the probe was covered with a black cloth to prevent any interference from natural or arti®cial ambient light sources.
(2) Laser Doppler Flowmetry Ð measurement of clitoral cavernosal blood¯ow. The effects of sildena®l on clitoral blood¯ow were assessed by Sildena®l augments nerve-mediated female genital arousal in the rabbit K Min et al laser Doppler¯owmetry. The principle of measurement is to utilize the Doppler shift of a projected beam of laser light that registers on a photodetector. A shift in the wavelength of detected light, proportional to the velocity of the red blood cells, is produced and blood¯ow values are expressed as mlamina100 gm of tissue. A laser Doppler¯owmeter (ALF21; Transonic Systems, Ithaca, NY) ®tted with a type NS24 needle probe was used. Clitoral intracavernosal blood¯ow was monitored before and after PNS. A mid-line incision (1 cm) on the labia over the clitoris was fashioned and the clitoris was exposed with the tunica intact. The probe was inserted longitudinally into the clitoral cavernosal tissue. To avoid movement artifact, the probe was ®xed in position by securing the probe cable.
(3) Measurement of vaginal luminal pressure. To assess the effects of vaginal smooth muscle relaxation on vaginal luminal pressure, we placed within the vaginal lumen a 9 Fr. pediatric abdominal pressure catheter (Life-Tech, Inc. Stafford, TX) connected to a PT300 pressure transducer. One port of the catheter was out®tted with a 3-way stopcock, attached to a syringe containing saline. The second port was connected to a PT300 pressure transducer. In order to measure vaginal luminal pressure, the catheter was inserted until the tip of the balloon was just below the cervix. After insertion of the catheter and appropriate placement of the balloon, the pressure within the balloon was adjusted to 10 mm Hg. To minimize the in¯uence of intestinal peristalsis, multiple layers of gauze were placed between the rectum and vagina, and rectal pressure was measured simultaneously. To exclude any potential changes in luminal pressure due to voided urine, the bladder was emptied continuously by needle aspiration through the bladder wall. We also recorded the duration of vaginal luminal pressure changes following PNS. This was de®ned by the time (seconds) observed for the decreased vaginal luminal pressure values to return to baseline.
(4) Measurement of vaginal lubrication. Vaginal lubrication was measured using a pre-weighed cotton-tipped¯exible cannula. Broad forceps were used as a vaginal speculum and the cotton-tipped cannula was inserted into the lower vagina. Unilateral PNS occurred for 60 seconds and the cannula was removed 5 minutes after cessation of PNS and weighed. Vaginal lubrication was assumed to be proportional to the weight of the¯uid absorbed by the cotton-tipped cannula. To prevent contamination by urine, both ureters were transected and bladder contents were aspirated completely by syringe.
Data analysis
For all oximetry data, the difference between baseline and peak amplitude values were measured (Figure 1 ). Response duration was de®ned as the time in seconds required for the peak amplitude to return to baseline following PNS. Similarly, data for other measurements were expressed as the change between basal and stimulated states (mean AE s.e.m.). Data were analyzed by paired t-test and determined to be signi®cantly different when the P-value 0.05.
Results
Effects of PNS and sildena®l on genital tissue engorgement
We examined the effects of increasing doses of sildena®l (5, 10 and 50 nM) on oxyhemoglobin following PNS at various frequencies (4, 16 and 32 Hz). PNS alone caused an increase in oxyhemoglobin concentration (Figures 2 and 3 ; Table 1 ). We observed a signi®cant increase in oxyhemoglobin at all frequencies in the presence of 50 nM sildena®l ( Figure 3A ; Table 1 ). Tissue concentrations of deoxyhemoglobin decreased signi®cantly with PNS in the presence of sildena®l ( Figure 3B ; Table 1 ).
In the presence of sildena®l, PNS caused a signi®cant increase in the duration of response, as assessed by changes in the concentrations of oxyhemoglobin, deoxyhemoglobin and total hemoglobin and oxygen saturation (Figures 2 and 4 ; Table  2 ). These effects were noted at 32 Hz for sildena®l at all doses. Figure 1 Representative laser oximetry recording indicating parameters that were measured to assess changes in tissue hemoglobin concentration. Amplitude was de®ned as the change in hemoglobin concentration betweeen the baseline to peak value. Response duration was de®ned as the time between the initiation of pelvic nerve stimulation (PNS) and the return to baseline. The pelvic nerve was stimulated for 30 seconds.
Sildena®l augments nerve-mediated female genital arousal in the rabbit K Min et al Sildena®l augments nerve-mediated female genital arousal in the rabbit K Min et al
Effects of PNS and sildena®l on clitoral blood¯ow
In control animals, PNS resulted in a signi®cant frequency-dependent increase in clitoral blood¯ow ( Figure 5A control). The duration of this response in control animals was prolonged in a similar manner ( Figure 5B control) . Interestingly, sildena®l did not enhance mean clitoral blood¯ow above that observed with PNS alone ( Figure 5A ). No signi®cant changes in the duration of response were noted with sildena®l relative to control ( Figure 5B ).
Effects of PNS and sildena®l on vaginal luminal pressure
PNS resulted in a frequency-dependent decrease in vaginal luminal pressure in control animals (Figure Sildena®l augments nerve-mediated female genital arousal in the rabbit K Min et al 6A control). Sildena®l at 50 nM caused a signi®cant decrease in vaginal luminal pressure at 32 Hz ( Figure 6A ). The increased duration of response was also signi®cant at this concentration and frequency ( Figure 6B ).
Effects of PNS and sildena®l on changes in vaginal lubrication
PNS alone did not cause measurable frequencydependent changes in vaginal lubrication. Sildena®l at 5, 10 or 50 nM, followed by PNS resulted in an increase in vaginal lubrication (Figure 7 ).
Discussion
The goal of this study was to de®ne the effects of sildena®l on pelvic nerve-mediated genital arousal in a female animal model. Genital arousal was assessed by determination of changes in genital blood¯ow, vaginal luminal pressure and vaginal lubrication. In this study, we have established in the animal model that PNS caused a frequency-dependent increase in genital blood¯ow. This was assessed by increased oxyhemoglobin (oximetry), as well as changes in clitoral blood¯ow determined by laser Doppler¯owmetry. The`mean changes' in hemoglobin concentration re¯ected, in part, acute hemodynamic responses in genital (vaginal, labial, clitoral) tissues secondary to PNS. Since there does not appear to be an active veno-occlusive mechanism in female genital tissues, the arterial blood¯ow may be the primary determinant of the state of engorgement. The`response duration' re¯ected, in part, hemodynamic engorgement or blood retention properties in genital tissues. Thus, these observations con®rm that genital tissue engorgement is regulated by PNS and that these genital blood¯ow changes are reproducibly recorded in this in vivo animal model.
Intravenous administration of sildena®l in this animal model resulted in a signi®cant increase in both the amplitude and duration of the nervemediated genital arousal response, as assessed by laser oximetry. However, sildena®l did not enhance clitoral blood¯ow by laser Doppler¯owmetry above that observed with PNS alone, presumably due to increased vasocongestion. Facilitation of genital tissue engorgement by sildena®l could transiently increase the resistance of the vascular bed in genital tissues and result in decreased blood in¯ow. Thus, these data indicate that sildena®l facilitates nervemediated physiological genital arousal. Further, sildena®l enhanced pelvic nerve stimulated changes in vaginal lubrication. Since vaginal lubrication is a plasma transudate re¯ecting genital blood¯ow, the increase is consistent with the ability of sildena®l to augment nerve-mediated physiological genital arousal. Administration of sildena®l also resulted in a decrease in vaginal luminal pressure. Since vaginal luminal pressure re¯ects, in part, the tone of the smooth muscle of the vaginal wall, these observations further support the effect of sildena®l to enhance nerve-mediated physiological genital arousal.
The doses of sildena®l administered in this study were 0.21, 0.42 and 2.1 mgakg, respectively. We estimated the total blood volume in a 4 kg rabbit to be approximately 250 ml. Based on these values, the total concentration (bound and free) of sildena®l in the plasma is expected to be, 5, 10 and 50 nM, respectively. It must be noted that binding of Sildena®l augments nerve-mediated female genital arousal in the rabbit K Min et al sildena®l to plasma proteins in vivo results in its partitioning and reduces the free and bioavailable sildena®l. Further, the conversion of sildena®l into other metabolites may also reduce the bioavailable sildena®l. However, the binding of sildena®l to plasma proteins is of low af®nity and is readily reversible, thus, re-establishing equilibrium between the bound and free. The doses administered in this study are very low compared to those reported previously in the male dog 15 , in which doses of 1 ± 100 mgakg were administered. In that report, 15 doses as low as 1 mgakg of sildena®l produced enhancement of the frequency response curve by electric ®eld stimulation. While the pharmacodynamics of sildena®l in the dog has been investigated they have yet to be investigated in the female rabbit. Indeed, without measurement of sildena®l in the plasma, in the rabbit, it is dif®cult to obtain accurate values for bioavailable and plasma bound sildena®l. Nevertheless, the changes in genital physiological parameters with the low doses administered in the rabbit suggest that sildena®l enhances pelvic nerve stimulated genital sexual arousal. Despite the low doses of sildena®l administered, a signi®cant change in the physiological parameters of female genital sexual arousal is observed in response to sildena®l with PNS. With these limited data it is not possible to clearly state if these changes are dose related. Relaxation of the vaginal muscularis involves multiple pathways. 6 ± 10 One of these is postulated to involve the NO-cGMP pathway. 9 ± 10 Studies in organ baths have suggested that sildena®l induces dose-dependent relaxation in vaginal tissues precontracted with norepinephrine. Studies in cultured human and rabbit vaginal smooth muscle cells showed increased cGMP synthesis in response to nitric oxide donors and sildena®l. 11 ± 12 Further, we have characterized phosphodiesterase type-5 activity in cultured smooth muscle cells of clitoral and vaginal tissue from human and rabbit. 11 ± 12 These observations suggest that the enhancement of genital engorgement by sildena®l, in the in vivo animal, is based on the signaling of NO-cGMP pathway mediated by PNS.
Despite the limitations of animal models and the approaches used for assessment of genital engorgement, we suggest a role for sildena®l in facilitating genital sexual arousal in response to PNS. In several large clinical trials, however, sildena®l did not show improvement in subjective female genital sexual arousal. 14 One possibility for this failure is the confounding and unknown effect of sex hormones on sildena®l action in genital arousal. In order to clarify the role of sildena®l in facilitating genital arousal in various hormonal states, further research is necessary to assess the effect of sildena®l on sexual arousal in response to sex steroid hormone deprivation and hormone replacement.
